Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Case Series
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,183 | Dovepress* | 8,888+ | 1,910 | 10,798 | |
| PubMed Central* | 1,295 | 664 | 1,959 | ||
| Totals | 10,183 | 2,574 | 12,757 | ||
| *Since 18 January 2017 | |||||
View citations on PubMed Central and Google Scholar